Drug Shortage Report for MINT-TOPIRAMATE

Last updated on 2018-01-04 History
Report ID 28570
Drug Identification Number 02315653
Brand name MINT-TOPIRAMATE
Common or Proper name Mint- Topiramate
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TOPIRAMATE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size Bottles of 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-11-07
Estimated end date 2017-12-15
Actual end date 2017-12-15
Shortage status Resolved
Updated date 2018-01-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-01-04 French Compare
v6 2018-01-04 English Compare
v5 2017-12-15 French Compare
v4 2017-12-15 English Compare
v3 2017-11-08 English Compare
v2 2017-11-07 French Compare
v1 2017-11-07 English Compare

Showing 1 to 7 of 7